Therefore, antibodies against IL-17 may be an effective treatment option for psoriasis and other autoimmune diseases.91–93 Further research on autoimmune diseases and the identification of additional immune disease-associated cytokines may provide new insights for future treatments. Here, IL17A is linked to autoimmune disease.